The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE and return to the consumer section of the site.
Yes, I am a US healthcare professional and would like to continue.
ContinueFOR US HEALTHCARE PROFESSIONALS ONLY
TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.
Important Safety Information
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE and return to the consumer section of the site.
Yes, I am a US healthcare professional and would like to continue.
Continue